Onxeo SA Valuation
| C4X Stock | 0.05 0.01 14.29% |
Onxeo SA seems to be undervalued based on Macroaxis valuation methodology. Our model determines the value of Onxeo SA from analyzing the company fundamentals such as Net Asset of 53.06 M, total asset of 53.06 M, and Current Valuation of 5.01 M as well as examining its technical indicators and probability of bankruptcy.
Undervalued
Today
Please note that Onxeo SA's price fluctuation is out of control at this time. Calculation of the real value of Onxeo SA is based on 3 months time horizon. Increasing Onxeo SA's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Onxeo SA's intrinsic value may or may not be the same as its current market price of 0.05, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.048 | Real 0.049 | Hype 0.04 | Naive 0.0345 |
The intrinsic value of Onxeo SA's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Onxeo SA's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Onxeo SA helps investors to forecast how Onxeo stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Onxeo SA more accurately as focusing exclusively on Onxeo SA's fundamentals will not take into account other important factors: Onxeo SA Total Value Analysis
Onxeo SA is currently anticipated to have takeover price of 5.01 M with market capitalization of 46.31 M, debt of 9.91 M, and cash on hands of . Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Onxeo SA fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
5.01 M | 46.31 M | 9.91 M |
Onxeo SA Asset Utilization
The concept of asset utilization usually refers to the revenue earned for every dollar of assets a company currently reports. The newest return on assets of Onxeo implies not a very effective usage of assets in March.About Onxeo SA Valuation
The stock valuation mechanism determines Onxeo SA's current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of Onxeo SA based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of Onxeo SA. We calculate exposure to Onxeo SA's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Onxeo SA's related companies.8 Steps to conduct Onxeo SA's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Onxeo SA's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Onxeo SA's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Onxeo SA's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Onxeo SA's revenue streams: Identify Onxeo SA's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Onxeo SA's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Onxeo SA's growth potential: Evaluate Onxeo SA's management, business model, and growth potential.
- Determine Onxeo SA's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Onxeo SA's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Additional Tools for Onxeo Stock Analysis
When running Onxeo SA's price analysis, check to measure Onxeo SA's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Onxeo SA is operating at the current time. Most of Onxeo SA's value examination focuses on studying past and present price action to predict the probability of Onxeo SA's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Onxeo SA's price. Additionally, you may evaluate how the addition of Onxeo SA to your portfolios can decrease your overall portfolio volatility.